Dataset Open Access
Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N.
Recent reports have identified errors and implausible results in the title paper, few of which have been corrected to date. To facilitate analysis, I provide a spreadsheet containing all data from tables in the corrected version (2020-05-29), from both the main text (html) and supporting information (PDF).
The data is uploaded to this publicly-funded repository with the permission of the copyright holder: "Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories ... with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source." Text and data mining are also permitted: "These articles are also available to download with rights for full text and data mining, re-use and analyses for as long as needed."
Name | Size | |
---|---|---|
Mehra2020-05-29-hydroxychloroquine-tables.xlsx
md5:a6eff2f1a05c021893ddaa96b576b1f2 |
42.6 kB | Download |
James Watson, 182 signatories. (2020). An open letter to Mehra et al and The Lancet. Zenodo. http://doi.org/dw8t
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet, http://doi.org/ggwzsb
All versions | This version | |
---|---|---|
Views | 1,409 | 1,409 |
Downloads | 98 | 98 |
Data volume | 4.2 MB | 4.2 MB |
Unique views | 840 | 840 |
Unique downloads | 92 | 92 |